BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12733839)

  • 1. Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.
    Ringler M; Göbel G; Möst J; Weithaler K
    Eur J Epidemiol; 2003; 18(2):161-70. PubMed ID: 12733839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Li YT; Luo XQ; Zhong XB; Cai LM; Zhu LP; Chen XQ; Wang KC; Chen ZG
    Vaccine; 2020 May; 38(23):3960-3967. PubMed ID: 32321685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M; Berginc N
    Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
    Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of vaccine-preventable diseases among young children in the United Arab Emirates.
    Al-Mekaini LA; Kamal SM; Al-Jabri O; Soliman M; Alshamsi H; Narchi H; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2016 Sep; 50():67-71. PubMed ID: 27457919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH; Srivastav A; Lindley MC; Fisher A; Kim D; Greby SM; Lee J; Singleton JA
    Am J Prev Med; 2022 Mar; 62(3):367-376. PubMed ID: 35190101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
    Jiles RB; Fuchs C; Klevens RM
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
    Minta AA; Andre-Alboth J; Childs L; Nace D; Rey-Benito G; Boncy J; Adrien P; Francois J; Phaïmyr Jn Charles N; Blot V; Vanden Eng J; Priest JW; Rogier E; Tohme RA
    Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination coverage in hard to reach Roma children in Slovenia.
    Kraigher A; Vidovic M; Kustec T; Skaza A
    Coll Antropol; 2006 Dec; 30(4):789-94. PubMed ID: 17243551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015.
    Jablonka A; Happle C; Grote U; Schleenvoigt BT; Hampel A; Dopfer C; Hansen G; Schmidt RE; Behrens GM
    Infection; 2016 Dec; 44(6):781-787. PubMed ID: 27449329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A
    Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.